News | June 08, 2024
Sun Pharma to acquire stake in HaystackAnalytics
HaystackAnalytics is engaged in the business of developing genomic analysis software
HaystackAnalytics is engaged in the business of developing genomic analysis software
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
Launch of 20 new medicines expected by 2030
95.7% of patients responded to Breyanzi in the TRANSCEND FL trial
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Investing in Malaysia's largest clinic operator to expand the healthcare business
Subscribe To Our Newsletter & Stay Updated
